Skip to content

OPIOID Study - Pain With Osmotic Dilators

OPIOID Study: Opioid Use and Pain After Insertion of Osmotic Dilators

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03710239
Acronym
OPIOID
Enrollment
68
Registered
2018-10-18
Start date
2018-10-02
Completion date
2020-03-11
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion in Second Trimester

Brief summary

Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.

Detailed description

This is a randomized controlled trial to assess and compare pain levels and pain medication needs following placement of Laminaria versus Dilapan-S for cervical preparation prior to second-trimester dilation and evacuation (D&E) procedures. Pain levels and medication usage will also be assessed following the D&E procedure itself, up to 7 days after the procedure.

Interventions

DEVICEDilapan-S

Synthetic osmotic dilator

DEVICELaminaria

Seaweed-based osmotic dilator

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants will not know what type of dilator they have been assigned, however the medical care team (including investigators) will be aware.

Intervention model description

Participants will be randomly assigned to receive one of two existing dilator times, with the remainder of care and study procedures being identical.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* scheduled D&E for 15+0 to 23+6 wga * ability to speak and read in English * ownership of smartphone with internet access and data plan

Exclusion criteria

\- chronic pain, fibromyalgia, active pelvic infection, inability to take NSAIDS, current use of narcotics

Design outcomes

Primary

MeasureTime frameDescription
Maximum pain above baseline following Laminaria versus Dilapan-S placementFirst 24 hours after dilator placementTimed surveys measuring pain on Numeric Rating Scale (0-10), administered approximately 24 hours after dilator placement
Time of maximum pain above baseline following Laminaria versus Dilapan-S placementFirst 24 hours after dilator placementTiming of maximum Numeric Rating Scale (0-10) pain difference among measurements approximately 24 hours after dilator placement

Secondary

MeasureTime frameDescription
Pain medication use after Laminaria versus Dilapan-S placementFirst 24 hours after dilator placementTimed surveys of pain medication usage at 2 hours, 4 hours, 8 hours, and approximately 24 hours after dilator placement
Maximum pain increase over baseline following D&E procedureFirst week after D&ETimed surveys measuring pain on Numeric Rating Scale (0-10), administered at 1 hour, 4 hours, 24 hours, 48 hours, and 1 week after D&E procedure
Pain medication use after D&EFirst week after D&ETimed surveys of pain medication usage, administered at 4 hours, 24 hours, 48 hours, and 1 week after D&E procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026